PerkinElmer, Inc. (PKI) To Go Ex-Dividend on January 17th

Share on StockTwits

PerkinElmer, Inc. (NYSE:PKI) declared a quarterly dividend on Wednesday, October 24th, RTT News reports. Shareholders of record on Friday, January 18th will be paid a dividend of 0.07 per share by the medical research company on Friday, February 8th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date of this dividend is Thursday, January 17th.

PerkinElmer has a dividend payout ratio of 7.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect PerkinElmer to earn $4.03 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 6.9%.

Shares of PKI opened at $83.51 on Friday. The stock has a market cap of $8.99 billion, a price-to-earnings ratio of 28.80, a P/E/G ratio of 1.64 and a beta of 1.11. PerkinElmer has a 12 month low of $70.74 and a 12 month high of $98.33. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.18 and a current ratio of 1.70.

PerkinElmer (NYSE:PKI) last issued its quarterly earnings data on Wednesday, October 31st. The medical research company reported $0.90 EPS for the quarter, missing the Zacks’ consensus estimate of $0.92 by ($0.02). The company had revenue of $674.30 million for the quarter, compared to analyst estimates of $676.72 million. PerkinElmer had a return on equity of 15.04% and a net margin of 4.71%. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.73 EPS. As a group, equities research analysts predict that PerkinElmer will post 3.6 earnings per share for the current fiscal year.

In other PerkinElmer news, Director Nicholas A. Lopardo sold 2,000 shares of the business’s stock in a transaction on Monday, November 5th. The shares were sold at an average price of $82.12, for a total transaction of $164,240.00. Following the sale, the director now directly owns 1,661 shares of the company’s stock, valued at approximately $136,401.32. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Alexis P. Michas sold 5,000 shares of the business’s stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $90.95, for a total transaction of $454,750.00. The disclosure for this sale can be found here. Insiders have sold a total of 19,000 shares of company stock valued at $1,609,550 in the last quarter. Insiders own 2.10% of the company’s stock.

Several research firms recently commented on PKI. Morgan Stanley boosted their price target on PerkinElmer from $95.00 to $100.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 10th. UBS Group began coverage on PerkinElmer in a research note on Tuesday, October 9th. They issued a “neutral” rating and a $100.00 price target on the stock. Janney Montgomery Scott lowered PerkinElmer from a “buy” rating to a “neutral” rating in a report on Friday, November 2nd. CIBC reissued an “average” rating and issued a $44.50 price objective on shares of PerkinElmer in a report on Thursday. Finally, Needham & Company LLC began coverage on PerkinElmer in a report on Wednesday, January 2nd. They issued a “hold” rating and a $79.00 price objective for the company. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. PerkinElmer presently has an average rating of “Hold” and an average price target of $82.90.

TRADEMARK VIOLATION NOTICE: This story was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/4072377/perkinelmer-inc-pki-to-go-ex-dividend-on-january-17th.html.

About PerkinElmer

PerkinElmer, Inc provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers analytical technologies, solutions, and services for the environmental market that enable its customers to understand the characterization and health of various aspects, including air, water, and soil.

Read More: What is the Dow Jones Industrial Average (DJIA)?

Dividend History for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Investors Sell First Data  on Strength
Investors Sell First Data on Strength
Investors Sell Vanguard Small-Cap Growth ETF  on Strength
Investors Sell Vanguard Small-Cap Growth ETF on Strength
Compass Minerals International  Lowered to “Hold” at Zacks Investment Research
Compass Minerals International Lowered to “Hold” at Zacks Investment Research
XPA Price Reaches $0.0575 on Exchanges
XPA Price Reaches $0.0575 on Exchanges
Ardor One Day Volume Reaches $406,666.00
Ardor One Day Volume Reaches $406,666.00
FundRequest  24 Hour Volume Hits $0.00
FundRequest 24 Hour Volume Hits $0.00


Leave a Reply

© 2006-2019 Ticker Report